Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neurotransmitters and apoptosis in the developing brain.

C Ikonomidou1, P Bittigau, C Koch

  • 1Department of Pediatric Neurology, Charité, Virchow Clinics, Humboldt University, Augustenburger Platz 1, 13353 Berlin, Germany. hrissanthi.ikonomidou@charite.de

Biochemical Pharmacology
|July 13, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quinolinate-like neurotoxicity produced by aminooxyacetic acid in rat striatum.

Amino acids·2013
Same author

Antiepileptic drugs and the developing brain.

Cellular and molecular life sciences : CMLS·2006
Same author

Acute and long-term proteome changes induced by oxidative stress in the developing brain.

Cell death and differentiation·2005
Same author

Modeling pediatric head trauma: mechanisms of degeneration and potential strategies for neuroprotection.

Restorative neurology and neuroscience·2003
Same author

Glutamate signaling and the fetal alcohol syndrome.

Mental retardation and developmental disabilities research reviews·2002
Same author

Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration.

Journal of neurochemistry·2001

Certain medications and alcohol can trigger brain cell death in developing mammals. This is particularly concerning during pregnancy and early childhood, potentially leading to developmental disorders.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Pharmacology

Background:

  • The immature mammalian brain undergoes a critical growth period (brain growth spurt/synaptogenesis) where it is vulnerable to neurotoxic insults.
  • Neuronal apoptosis can be induced by disruptions in glutamate N-methyl-d-aspartate (NMDA) receptor function or excessive gamma-aminobutyric acid type A (GABA(A)) receptor activation.
  • Agents like anesthetics, anticonvulsants, and drugs of abuse can act as apoptogenic agents during this sensitive developmental window.

Purpose of the Study:

  • To investigate the mechanisms by which certain agents induce neuronal apoptosis in the developing brain.
  • To highlight the specific risks associated with ethanol exposure during pregnancy.
  • To raise awareness regarding the potential neurotoxic effects of common medical agents used in pediatric and obstetrical care.

Related Experiment Videos

Main Methods:

  • Review of existing literature on neurodevelopmental pharmacology and toxicology.
  • Analysis of the mechanisms of action for various apoptogenic agents on NMDA and GABA(A) receptors.
  • Correlation of developmental timing with vulnerability to neurotoxic insults.

Main Results:

  • Transient blockade of NMDA receptors or excessive activation of GABA(A) receptors triggers neuronal apoptosis in the immature brain.
  • Ethanol exhibits both NMDA antagonist and GABA(A) agonist properties, making it a potent inducer of widespread apoptotic neurodegeneration.
  • Maternal ethanol ingestion during the third trimester can lead to fetal brain dysmorphogenesis and neurobehavioral deficits characteristic of Fetal Alcohol Syndrome.

Conclusions:

  • Ethanol exposure during critical developmental periods poses a significant risk for neurodevelopmental abnormalities.
  • Medical agents used for anesthesia, sedation, or seizure management may also induce apoptotic neuronal death in the developing human brain.
  • Further research and caution are warranted regarding the use of these agents in pregnant women and young children.